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NCA (nonspecific cross-reacting  antigen), a glyco- 
protein found in normal  lung  and spleen, is immuno- 
logically related to carcinoembryonic antigen (CEA), 
which is found in  over 95% of colon adenocarcinomas. 
From a human genomic library, we previously cloned 
part of an NCA gene and showed that  the amino-ter- 
mind region has  extensive sequence homology to CEA 
(Thompson, J. A., Pande, H., Paxton, R. J., Shively, 
L., Padma, A., Simmer, R. L., Todd, Ch. W., Riggs, A. 
D., and  Shively, J. E. (1987) Proc. Natl. Acad.  Sei. U. 
S. A. 84,2965-2969). We now present  the nucleotide 
sequence of a cDNA clone, containing  the entire coding 
region of NCA (clone 9). The clone was obtained from 
a X g t l O  library made from the colon carcinoma cell 
line SW 403;  the clone contains  a 34-amino acid leader 
sequence, 310 amino acids  for  the  mature  protein,  and 
1.4 kilobases of 3’-untranslated region of the NCA 
gene. A comparison of the NCA sequence to  the CEA 
sequence (Oikawa, S., Nakazato, H., and Kosaki, G. 
(1987) Biochem. Biophys. Res. Commun. 142, 511- 
618; Zimmerman, W., Ortlieb, B., Friedrich, R., and 
von Kleist, S. (1987) Proc. Natl. Acad. Sci. U. S. A. 
84, 2690-2694) shows that both proteins contain 
doublets of an immunoglobulin-like domain, of which 
there are one copy in NCA and  three copies in CEA, a 
108-amino acid amino-terminal domain with no cys- 
teine residues, and a carboxyl-terminal hydrophobic 
domain of sufficient  length to anchor the glycoproteins 
in the cell membrane. Overall, the  corresponding cod- 
ing regions possess 85% sequence homology at the 
amino acid level and 90% homology at the nucleotide 
level. Forty nucleotides 3’ of their stop codons, the 
CEA and NCA cDNAs become dissimilar. The 108- 
amino acid amino-terminal region together  with part 
of the  leader peptide sequence corresponds  exactly to 
a single exon described in our previous work.  The data 
presented  here further demonstrate  the likelihood that 
CEA recently evolved from NCA by gene duplication, 
including two duplications of the immunoglobulin-like 
domain doublet of NCA. 
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Carcinoembryonic antigen (CEA)’ is a 180-kDa highly  gly- 
cosylated glycoprotein. CEA  was first described by  Gold and 
Freedman in 1965 (1) as a colon tumor-associated antigen. 
Immunoassays for CEA have found wide acceptance as a 
diagnostic tool in primary clinical diagnosis of colon cancer 
as well as  in the long term monitoring of patients following 
colorectaI tumor resection. The original concept that CEA is 
a tumor-specific antigen was abandoned when small amounts 
of  CEA were found in normal  adult colon (2, 3). In addition, 
several CEA-related antigens expressed in  normal and malig- 
nant tissues have been described. NCA, the nonspecific cross- 
reacting antigen, was first described in normal lung and spleen 
in 1972 (4, 5). Using monoclonal antibodies, Buchegger et al. 
(6) have differentiated between two molecular weight forms 
of NCA NCA-55, a 55-kDa glycoprotein found in granulo- 
cytes and epithelial cells, and NCA-95, a 95-kDa glycoprotein 
found only in granulocytes. Other CEA-like antigens include 
a unique 128-kDa colon tumor-associated antigen (7), two 
meconium antigens of molecular weights 160 kDa (NCA-8) 
and 100 kDa (7,8), and  an 85-kDa biliary glycoprotein (BGP 
I) (9). CEA-like antigens in the serum of normal blood donors 
have been isolated and characterized with monoclonal anti- 
bodies to CEA (10). Four antigens with molecular weights of 
200,  180,  114, and  85 kDa were found. The 180- and 85-kDa 
antigens correspond to CEA and BGP I, respectively. The 
identities of the remaining antigens  are unknown, but  these 
and  the meconium antigens may arise from CEA, BGP I, and 
NCA  by proteolytic cleavage or may  be distinct gene products. 
All  of the antigens are obviously related by sharing common 
antigenic determinants  but, in most cases, each has also been 
shown to possess unique antigenic determinants. For CEA 
and NCA, amino acid sequence information has demonstrated 
extensive sequence homology between the two antigens and 
placed them within the immunoglobulin supergene family 
(11). 
Earlier, we reported the sequences of a partial genomic 
clone for NCA (12) and cDNA clones for CEA (13). These 
data demonstrated that CEA and NCA each contain a 108- 
amino acid amino-terminal domain which has no cysteine 
residues. In addition, CEA contains multiple copies of a 
domain of 178 amino acid residues, each of which has four 
cysteine residues and presumably, two disulfide loops.  Oikawa 
et at. (14) obtained  a  near full-length clone for CEA, extending 
our data  and confirming the occurrence of three copies of this 
178-amino acid immunoglobulin-like domain in CEA. 
The abbreviations used are: CEA, carcinoembryonic antigen; 
NCA, nonspecific cross-reacting antigen; kb,  kilobase; BGP, biliary 
glycoprotein; IPTG, isopropyl-1-thio-0-o-galactopyranoside; bp, base 
pairs. 
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NCA  cDNA Clone 3203 
Since the biological role of CEA and its relationships to 
other members of its gene family is  still  not clear, we have 
continued our efforts to isolate and characterize CEA-like 
genes. In  this report, we present data on an NCA cDNA clone 
isolated from a colon tumor cell line and a comparison of 
NCA with CEA. 
MATERIALS AND METHODS 
Chemicals-Nitrocellulose filters were purchased from Schleicher 
& Schuell. Restriction enzymes were from Boehringer Mannheim and 
Bethesda Research Laboratories. SI nuclease, T, polymerase, T, 
kinase, and T, ligase were from Bethesda Research Laboratories. 
Avian myeloblastosis virus reverse transcriptase was from Life Sci- 
ences and deoxy and dideoxy nucleotides were from Pharmacia  LKB 
Biotechnology Inc. For sequencing with T7 polymerase, the Sequenase 
kit from United States Biochemicals were  used. Sequencing of single- 
stranded DNA was performed using the Amersham Corp. sequencing 
kit. [a-32P]dATP,  [y3'P]ATP,  [LY-~'P]~CTP,  and  [(u-~'S]~ATP were 
from Du Pont-New England Nuclear. All other reagents were of 
analytical grade. 
Construction and Screening of the cDNA Library-Total cyto- 
plasmic RNA  was prepared from SW 403 cells according to Dashal 
et al. (15) and cDNA was synthesized from 5 pg of poly(A)' RNA 
essentially as described by Maniatis et al. (16). Double-strand cDNA 
was rendered blunt-ended with T, polymerase and  then treated with 
T, kinase to ensure that all 5' ends of the cDNA molecules were 
phosphorylated. 
For convenient cloning into XgtlO, asymmetrical EcoRI adapters, 
also containing  a ClaI site, were added to ends of the cDNA  by blunt 
end ligation (16). The sequence of the adaptor was 
5"AATTCCGTATCGATGTGC 
GGCATAGCTACACG-5' 
The ClaI site is underlined. Only the 5' end of the shorter strand (14 
nucleotides) was phosphorylated, and a 200-fold excess of adaptor 
over calculated cDNA ends was used during the ligation reaction (16). 
After size selection by  gel electrophoresis and phosphorylation of the 
5' ends,  fragments larger than 600 bp  were cloned into dephospho- 
rylated arms of X g t l O  (Stratagene, San Diego, CA). For in vitro 
packaging, Gigapack packaging extracts (Stratagene) were used. A 
total of 5 X 10' independent  recombinant clones were obtained. The 
library was amplified using CES 200 cells (rec BC-), which reduces 
loss of clones containing repetitive sequences (17). Approximately 2 
X lo5 clones were screened according to the method of Benton and 
Davies (18) with a 1400-bp EcoRI fragment from the genomic NCA 
clone X39.2, which codes for a portion of the Ig-like domain of  NCA 
(12). Seven strong positives were obtained. Rescreening was done 
with a 561-bp SalL3A fragment of the same genomic clone that codes 
for a portion of the amino-terminal domain of NCA. One clone (clone 
9) was found to be positive with this probe. Labeling of the probes 
was performed as described elsewhere (191, and hybridization condi- 
tions were as given in the protocol by Cami and Kourilsky (20). 
Subcloning into a Phugemid Vector-Restriction analysis of clone 
9 showed that  the insert was 3.5 kb and contained an EcoRI site. The 
two EcoRI fragments of the insert were 2.1 and 1.4 kb. The 3.5-kb 
insert obtained by ClaI digestion and  the EcoRI fragments were  gel- 
purified and subcloned into the phagemid Bluescript (Stratagene), 
which can be used to produce either single-stranded DNA or super- 
coiled double-stranded DNA. 
Because color discrimination was poor and only one orientation of 
the insert DNA could be obtained in recombinant clones, a procedure 
involving plating on nitrocellulose was developed. In some experi- 
ments the transformation mix  was spread directly onto nitrocellulose 
filters on LB/amp  plates lacking IPTG  and X-gal. After overnight 
growth of the transformed bacteria, the nitrocellulose filters were 
transferred onto plates  containing  5 mM IPTG  and 40 pg/ml X-gal. 
Excellent color discrimination was obtained 2 to 4  h  after  transfer to 
the plates containing inducer and substrate. Plasmid DNA from 
recombinant clones was prepared by the method of Hattori and 
Sakaki (21) or by banding in cesium chloride gradients (16). 
DNA Sequence Determination-The 1.4-kb fragment was se- 
quenced by standard M13 single-stranded DNA methods. The 2.1- 
and 3.5-kb fragments were sequenced by using double-stranded plas- 
mid DNA. Three different enzymes and procedures were used at  
various times. Sequencing with T7 polymerase was performed with 
the Sequenase kit from United States Biochemicals adapted to dou- 
ble-stranded sequencing. Commercially available Bluescript sequenc- 
ing primers were used (Stratagene) or, alternatively, 17- or 18-residue 
oligonucleotides were designed from  known sequences of the  insert 
DNA. Supercoiled plasmid DNA (2 pg)  was alkaline-denatured in 100 
mM NaOH in  a total volume of  22 pl and heated to 65 "C for 5 min. 
After addition of 50 ng of the respective primer, the sample was 
neutralized by addition of 2 pl of 1 M sodium acetate,  pH 4.5, quickly 
precipitated with 2.5 volumes of 100% ethanol and kept on solid dry 
ice for about 20 min. The DNA  was then pelleted by centrifugation 
in a microfuge for 10 min at  4 "C, washed once with 70% ethanol, 
and dried. Annealed primer/template hybrids could  be kept up to 2 
weeks at -20 "C. 
For sequencing with avian myeloblastosis virus reverse transcrip- 
tase and Klenow polymerase, nucleotide working solutions were as 
given  by Zagurski et al. (22) and Strauss  et al. (23). The dried primer/ 
template hybrids were resuspended in deionized water and  the appro- 
priate reaction buffer to give a volume of 15 pl. Four pl of [a-35S] 
dATP (500 Ci/mmol) were added and  the sequencing reactions were 
carried out as described (22.23). For sequencing with the Sequenase 
kit the primer/template hybrids were resuspended in  a total volume 
of 15 pl consisting of the reagents supplied with the kit and 10 pCi  of 
[a-36S]dATP. The sequencing reactions were then performed accord- 
ing to  the United States Biochemicals protocol. Samples were run on 
4-8% polyacrylamide gels  (0.4 mm), using standard size gels as well 
as 85-cm-long gels with up  to two loadings per sample. 
RESULTS 
A cDNA library was constructed in X g t l O  using mRNA 
isolated from the colon carcinoma cell line SW403 and 
screened with a 1400-bp EcoRI probe from a genomic NCA 
clone (12). Seven positives out of 200,000 clones were ob- 
tained, one of which (clone 9) also hybridized with a probe 
specific for the amino terminus of  NCA. Restriction analysis 
of this clone with EcoRI revealed two fragments of size 2.1 
and 1.4  kb. When the clone  was cut with ClaI the full-length 
3.5-kb insert was obtained. The 2.1-kb fragment hybridized 
to probes from the coding region of NCA or CEA. Both EcoRI 
fragments as well as  the 3.5-kb ClaI insert were subcloned 
into  the respective polylinker sites of the phagemid Bluescript. 
Restriction analysis and T-tracking of recombinant clones 
containing the 2.1-kb fragment showed that only one orien- 
tation of the insert was obtained when the colonies were 
grown in the presence of IPTG and X-gal. However, by first 
growing the cells on nitrocellulose filters without induction 
by IPTG,  the opposite orientation of the  insert was obtained. 
We also observed a considerable improvement of color  devel- 
opment when  fully  grown colonies were induced by transfer- 
ring the filters to plates containing IPTG  and X-gal. 
The 1.4-kb fragment was sequenced by standard dideoxy 
methodology using single-stranded DNA (24). However, the 
r=- 
I 
2W bp 
FIG. 1. Restriction map and sequencing strategy for NCA 
cDNA clone 9. The 3.5-kb insert contains 1.0 kb of 5"flanking 
region, 1.5 kb of 3'-untranslated region, and 1032 bp of an open 
reading frame. The open reading frame, shown by boxes, contains  a 
leader sequence (L, 102 bp), an  amino-terminal domain (N-term, 324 
bp), an Ig-like repeat  (repeat, 528 bp), and  a carboxyl-terminal domain 
(C, 78 bp). The internal EcoRI site begins at nucleotide 2108. Hori- 
zontal arrows indicate regions and orientation of sequence analysis. 
The vertical bar indicates the position at which a cloning artifact  in 
clone 9 may have occurred resulting in the fusion of the NCA  gene 
to an unrelated sequence of  974 bp 5' of nucleotide -46. (See text for 
a discussion of the 5"flanking region.) 
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3204 NCA  cDNA Clone 
a 
974 bp that flank the NCA gene at ita 5' 
FIG. 2. a, nucleotide sequence of the 
end in clone 9. (For a discussion see 
text.) The cloning adaptor is shown in 
broken lines. b, nucleotide sequence of 
the NCA cDNA  gene. The open reading 
frame begins a t  nucleotide 1, indicated 
by the first horizontal arrow. The second 
horizontal arrow indicates the amino ter- 
minus of the mature protein. The third 
horizontal  arrow indicates the beginning 
of the Ig-like repeat, and  the fourth the 
beginning of the hydrophobic, carboxyl- 
terminal domain. The stop codon and 
internal EcoRI site are boxed. The ver- 
tical  arrow indicates the proposed poly- 
adenylation site, followed by a 14-nu- 
cleotide poly(A) tail (underlined). The 
asymmetric cloning adaptor is shown by 
broken lines. 
b -46 C 1 t A A ~ T C C T C T U : M A U G G T G U C A U U A U C A ~ A U U C C  ATG G U  CCC CCC 1CA ( E C   C C l  
] : P P S A P  
ACG cu TIC MT G r c  m UG ~ G G  AIG w GIT c n  crc at c l t  uc C T G  ccc cu MT ctr iTr G G ~  r A c  Aa2% T ~ C  uL tcG w AU GTG 
Ga uc ACT C I A  ATT t u  GU TAT AT& G U  ACT CAA cu at Act tu GtG ccc a A  r e  GGT cu w 2: A T 1  m c  ccc a h  T c c  
D G N S L I V G ~ V I G T ~ P A T P G ~ A ~ ~ G R E ~ I V P N A S  
1 P F N V A E G K i V L L L A H N l P Q N R l G l S Y t K G i R V  
CTG ClG A l C  C I G  ALc GTC ACC ChG A T 1  W ACA G U  I l C  1 A l  ACC C I A  C M  GTC A l A   A I G  1U U T  C l l  GlG U T  UL d % A  ACC G U  C I G  1TC  AT 
L L l Q N V l ~ N O l G F Y l L P V I K S O L V U E i A T G Q ~ H  
~c ACA y c  ~ l t  CTG TGG IGG GTA UT CGT CIG A a  CTC CCG GTC ACT ccc IGC C T G  CIG CTG  TCC AAT Ga AAC ATG ACC crc €02 ACI C T A  crc h a  GTC 
T V L Y Y V N G O S L P V S P R L Q l S N G N n l l l l l S V  
AM AGG U T   a A  GU TCC 111 GU 167 W AlA C I G  M C  CCA KG AGT OtC AU C C  A G l  Ut CCA G l C  ACC CfG Ml GTC 700 C E  TAT GC CCA U T  
K R  D A G S V t t ~ l Q N P A S A N R S D ~ V l l N V L V G P O  
G P T I S P S K A I Y , R P G E W L N L S C H A A S N P P A Q 1 S Y  
111 A l C  Ml GEG ACG 1TC CAG C M  TCC ACA C M  WG C l C  111 A l C  CCC AM ATC ACT GlG MT Ml Aa G U  TCC TAT AlG la CM 900 E C   C I l  AU 1 t A  
T I U G T F Q Q S T P E L F 1 P N l T Y I N S G S V ~ C ~ A H U S  
A T G L N R T T V T I I I I V S ( G A P V l S A V I T V C I T I G V  
C l G  CCC AGG GTC a1 CTG A T A ~ A ~ C C l G G ~ G l A l l T T C U l A l l l C f f i U A U C T G ~ A U T l G U C C A U C C C ~ ~ C l A ~ ~ C C T C C M l C C C A l T l l A l C C A l G W C C A C l  
L A R V A L 1  
A M L I C M C G T C T K T C l E T C C l U L G t C C T A T A l G C T ~ U T G W C M C l C M T U A M T l T W ~ C C C T C l G t C C l U G G l G l G l G C C L C T C A G L U C l T ~ A C C l M C l A G L U C f f i ~ I  1PW 
A C T E M C A l G G l U t l M l l U C ~ l l C A C A C T A l G W C A G t l T T T C C C M U T G T C ~ C M G L C T C C T C A I C A l U l M ~ T C l T A C C C C C ~ T I M l I T G T t C l T C C ~ l A T O C C l E C T C l  1300 
GE ccc ACC 111 rcc ccc TU AIG EC MT TIC ccr c u  G ~ G  U MT CTG AU crt Tcc TCG CAC ou at TCT MC CCA ccr 8w CA c y .  r A c  T C T  TGG 
EC A c r  Ga CTC MT AU ACC IU GTC ACG A X  AIC AU GTC TCT GU KT a1 CCT GIC CTC ru DT GTG ac ACC GTC ca A T C  1 wo ACG 111 GU GTG 
1400 lTC(+TlGCCAGUTUlElGlUlTAGTAlTCAUAUAGlA(ETlCAWGGGTMCTfMCA~GTA~CAUTTC1AlClTGlCMlCCCMCCflT~~~lMlAAGIUlCCTlTAGT~ACCC 
AGl~CT~CATTA~AOCAlCTllMCACIOCCGlGTGTTUUTGlACAGlGGTCClTllCAMG~l~~llClAUClUCCIGTlCTCACfCCCTGllTlMTTfCMCCCA~CAT(EMItCA 
A A T M T A W l l G C T C C C T A C C A G C f ~ ~ ~ G W G l C l G l ~ A G T T T C l ~ C A C T T G T l G ~ l ~ C A l ~ T ~ I A C M T f f i G l A l C t t l ~ ~ C l M G l l G T A ~ l l M ~ l G l ~ I ~ T G  1700 
GT~TGttTACACTCATCTUCTCAllC~llAlIClAllllAGTlGGlTlGTAlCTlUClMffilEGlAGlCCMClCllGGlATTACCClCClMlAGTCAl~~~GTAGlCAlACTCCCTCGlGT 1600 
~ G l G l l \ T l C I C l U I A O C T l l W T G I C l E A T G t A ~ C A & C A l U U T A G l W T G G l C T C I C l T T G l i T G U L ~ ~ M C l C A U U M T G l G l ~ T C h G ~ W C A l C A l M C C C A l U A ~ T A  
I I G C C C C I M T f f i T G G T M C l U l M l A G C A C l M l E l l M U l l l f f i l C A C A C l C T C l C A C C l A t G T U G t G C A T T U t C C I t T G G f t C T A M l G C l A C A l A C l C C M C T U M T G T T A I G U l U f f i  
A ~ A ~ ~ C C M T T U U " L ~ T T A U I C C M T T T U A U M P I U I W C A C ~ ~ ~ U U ~ C C C A G ~ C ~ A C ~ ~ U ~ T T A G C A ~ M T A C A G U G ~ C C C C ~ C ~ A C T ~ ~ A A C ~ T T T A C ~ G T A A C C T U A C ~ M  23W 
~ C l ~ l G l T I C C M l C I A T T ~ A l l T C I G I C G T T C T G l T l C C l l G l l C C A A l l l U C ~ C C C A C l C l T C l l G l A l T G l A l ~ ~ ~ ~ U ~ l I T C A C l G l A C l T G T A U ~ ~ G G l ~ l ~ l T l ~ l C  
C I l ~ l C A C U I l ~ E A A l T A C C l C I A I M C l ~ ~ ~ ~ ~ ~ ~ ~ ~ A ~ ~ ~ ~ ~  
22m 
21w 
I" 
2500 
2.1-kb EcoRI fragment and  the 3.5-kb full-length insert were 
directly sequenced using double-stranded supercoiled plas- 
mids (22, 23). For sequencing of double-stranded DNA, best 
results were obtained with the T, DNA polymerase. For the 
3.5-kb subclone, only the region around the  internal EcoRI 
site was sequenced, demonstrating that no small fragment 
was lost during subcloning. The restriction map and sequenc- 
ing strategy is shown in Fig. 1. Clone 9 has  a long 5'-flanking 
region of 1020 bp, followed  by an open reading frame encoding 
34 amino acids of a leader peptide, 310 amino acids of the 
mature protein, and 1430 bp of a 3"untranslated region 
ending in a poly(A) tail of 14 adenine residues. The entire 
sequence of clone 9 is shown in Fig. 2. Recently, a partial 
genomic clone for NCA has been reported by us (12) and 
Oikawa et al. (31).  The genomic clones contain almost 600 bp 
of sequences upstream of the  start of the NCA signal peptide. 
The nucleotide sequence of the 5'-flanking region of clone 9 
(the cDNA containing the NCA gene) diverges from these 
genomic sequences at position -46 upstream of the  transla- 
tional start.  The genomic sequences surrounding nucleotide 
-46 could  be interpreted  as an acceptor splice signal (32). To 
test the hypothesis, whether the divergence was due to  an 
alternative splicing event in the precursor mRNA, we re- 
screened the cDNA library with a probe specific for the  5'- 
flanking region of clone 9. Two independent clones (cDNA 
clones 13  and 2-3) with insert DNAs of 1.9 and 1.5 kb were 
obtained and partially sequenced (Fig. 3). They match the 
sequence of the 5'-flanking region of clone 9 (containing the 
NCA gene) only upstream of nucleotide -46. While there is 
no  homology to  the NCA gene downstream of this position, 
clones 13 and 2-3 show identical sequences, which makes 
them likely to be transcripts of the same gene. Both clones 
have the polyadenylation signal AATAAA, and clone 13 pos- 
sesses also 23 adenine residues. In addition, the sequences 
surrounding the position of divergence  from  clone 9 show  no 
indication for a donor splice site. Furthermore,  Northern blot 
analysis of total RNA obtained from SW 403 cells shows  two 
NCA clone 9 A A T G C T l T T C T A A T D G C X T T I E T G C T T T  
clone 13 AATGCT'ITTCTAATGTATTAACCCTAATDTATTAACTTPGAOPATNXlRGPTT 
clone 2-3 AATGCTTTTCTAATGTATTAACCTTVGTA!lTCXAGTTGCTGCTTT 
1 
NCA clone 9 G K T C N I I X T Z C X T ~ ~ ~ ~ ~ ~ ~ C ~  
clone 13 ~ ~ A ~ ~ ~ T T ~ ~  
clone 2-3 C X A C V A ~ A ~ ~ T W T T ~ C C l  
-46 
10 
NCA clone 9 GACCCCCCTCAGCC 
clone 13 R4R4pR4R4ApAAA 
FIG. 3. Comparison of the clones 2-3 and 13 with  clone 9 
containing  the NCA gene. Sequences upstream of nucleotide -46 
are  shared among the three clones (boldface letters). Sequences unique 
to  the respective clones are  in lightface letters. The putative polyad- 
enylation signals are underlined. Numbering refers to clone 9. The 
translational start site for NCA is shown in underlined boldface letters. 
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FI . 2. a, nucleotide sequenee of the 
974 bp that flank the  gene at its 5' 
end in elone 9. (For a diseussion see 
text.) The cloning adaptor is sho n in 
broken lines. b, nucleotide sequenee of 
the  e  gene. he open reading 
fra e begins at nucleotide 1, indieated 
by the first Iwrizontal arro . he second 
Iwrizontal arro  indieates the a ino ter-
inus of the ature protein. he third 
horizontal arrow indieates the beginning 
of the Ig-like repeat, and the fourth the 
beginning of the hydrophobie, earboxyl-
ter inal do ain_ he stop eodon and 
internal co I site are boxed. e uer-
tical arro  indieates the proposed poly-
adenylation site, follo ed by a 14-nu-
c1eotide poly(A) tail (underlined). he 
asy etrie cloning adaptor is sho n by 
broken lines. 
 cDNA l  
I ~ .'~~ TJ~~(jl~.lC~ !ß}.I~AGAA TGa: TTCGOC Tce TTTCOCCOC eGGT'" ffOGGTGTATA r~ TceeAC TC TC"'C fClCA,. AGGA~t'" TC TCfAAGl AGA TCA' A T A(:ACCAGM T ACC&GCGGCG'A 
GGAIZCGAAGC TCAAGGGTMA~AGT AGI.M TA TU. TTCAGTMACAA TM JGTGHiMC lrTT.fiOCA TG~ TM r NiGOC'" TGGAC TGolG Ta: T OC TA TC r TGMA TGra:ACAGGfACAC TTAteT T 100 
T Tl TTn THTTT TTTMGT Tl TTCCCA TTCAGGA TAAtAACA TT&TGA TC TGTAC TACAGGM,CCM,A 1GfC" TGeerCA TACATGTGGC TA TMAGJACATMAAU. TI. TC TMe u r TCA TAATGTGG ~ _ . ~ 
GGI GGGTAA T AC TGe JGTCiMA TM TGI AAGMGC TnTCA(' TAJN.MAA TGe'" T TAC TlTC"'C T TMeAC TACiACACCAGGTCGAAAA TT T TCAAGGTTATAGrAC. n ... T Tle"ACAA. T TCT TAGAGl 
T Q: T.AGe T "GTGYT GlAtZ. TTMM T AOC ITl AT T Aß. TOCTGM T 'GTGA T Tl Tl TTA TOCCMM T Tl TTTT m TerM TCA T TGA TG\ r "ocr TGGAM TMIt TM TTA r OCCA TGOCA Tl T Gt.C ACT 
ICAn Ancc IA !MGM Tl ... TlGAG TTTAGAGAGAA ,GGiil2IGTl ... Ge lGA TlA Tl MCAGI IAC lGAM ICW IM IAn A TllGT IACAnA I ICCA Tl IGIA I I Tl AGGT TTCC I Tl TACA I 
IC I I TlA I A ICJ:I!IflIC ''''CA TlACA lAI TTT TTMGAC TA IGGW IM T Tl ...... Tl IMGe TC IGGIGGA 'GA TTA TC lGe IMGI lAGTC lGAW IGIM JA TlT m I AA TAC TGTM TA TACC 
TG TC.ACACMA T IX 1 n TC TU. TeTA Tl AACC n GAGTA Tl OC.AGTT Ge T Cl: Tl T GI 
 -46 FcrCAAa:TccrcrAC.u~CÄiGTG ACAGAG AGACAO "'G GAC   GII. cce cce T  ocr (CI 
"G PSAP 
cce Ta: AGA TlG (AT ere cce H'aG ANj GAG GTC eTC CTC -.cA OCC TCA eH OA Ace He teiG AM. CCA cce Ace ACT OCC JE, CTC ... Cl ATT GM Tee 100 ~
PCRlHYPWKEVllTASllTfWNPPYTlKl TIES 
• 200 
eG (CA He AAT c a:.A GA  GGG A  GAG 6fT elT cu. occ ( AC AN:. (TG e (AG T (Cil A T GI T ( C[ TGG AC AAA GC  W CA IG 
T rNVAEGKE PQHRIGTSWTlGrRV 
~r Ge Me GI (TA n eTA ~ T GTA A GA "'1 M CM ocr Ce (CA G  (ce OC  TN: "GT T (GA ~ lc~ TA TAt e ,ur OCA e 
SlIVGfVIGTQQAJPGPATS RETI'fPNAS 
'00 G G re (Al> K. lC ce A  l  GA( O. GA TTe TAT  crA A}. e T  UG Tc.- GAY Tl T  MT rN. GU OCA e GA A{; He (AT 
llIQNVT Q HOTGfYT QYIKSOLVM[[ATGQJM 
~ 500 GTA TA( eCG GAG ClG CCC AAG CCC lec ATe Tee All: Me Me Tee AAC CCC GTG GAG !i'.C A,~ GA.T (Lr (iT(i oce Tl, ACe TGT GM CCI GAG COl1 ( AG VYPElPkP S JSSNNSNPY[OKDAYArTCEP(YO 
600 
Me A ACe TAC eTG ei  TGG Y  ..... T Gel AG 9: le eeG le Gl ce  ~ eTG AG (TG lee M  ca: M. TG e eTe er eTA er  A([ eTe 
H T'rlWWYN6QSl Y PAlQlSHG"" T l S Y 
700 
 A G AN:.. GAT IXA eiA ec TAl M HiT GM TA eAG e co. Ge  T oce JC. eo: GT GtC ceA Te .. cc eTG T lC le AT a: ceA rA  
fltOAGSYECEIQHPASAI(RSOPVTlHVlYGPD 
800 GGC cce ce ATT T e ee CA N:, O C T AC CGT CCA GG W. T TG N:. CTC CC  (A( OCA OCC T e ceA eT OCA (AG T C eT lGG 
 lI S P S K A H Y R. P G ( H l fit L S C HAI.. S I( P P A Q 'f'  W' 
. ~ 
TTl Te T G Ii TlC  CA}. ce A AA GHi erc TTT T  CCC N:. TC T TG T (I: ~ ce l TG T :  OC( CAl' ß( TC  
r H FOQSTQElr IPI({TVJltNSGS,"COAHNS 
~ 1000 Ge( CT : eTC  GG. C N:,J.. rc 6 .HG Te CA le T GA ACT ocr l TC eTC TCA OCT GTG OCC ce Te GOC TC eG AH ~ GTG TT lMITVSGS lSAYA YGI G  
lG Ge  Nil:; lC Gel lG ATA ~AO CCIGGIGlAlTTTCGA'~TTIC"'& AGAC IGGeA&lTTGGACCAGACCC~~CT'GeTCCTCCAA CC AlTITATCCA GGMCCACl L) 
1200 
MAAACMGGTC TGC TC IGelce IGMGCCC TA TA GC TGG,AGA G(iACAACT AA TGMAA TTTMAGGCä.U..U.eC TCAG C  TGAG  TGT TGCCA TC"GAGAC T TC.AC  T Me T AGAGACAGGeM 
1100 
AC TGC ACeA TGGTGAG A TtGAeGAA  TTe AC TA TGG CAGClf  CCeAAGA CMAAeAAGACTCC T ltCATGA TMGGe. TC T T ce  nT TM T T TCTCC HGC  TA Toce GC TC T 
"0  1~ 
TTCGC TTGGCAGG\ TG\ TOC TGTCA TI AGT A HCACAAGAAGT AOC TTCAGAGGGTMeTT MCAGAGTA TCA~ TlC TA TC HG reM rCCCUCG r TT T ACA TA._.u TAAGA~ TCC n rAGT a:Aece 
1600 
AGTGA   GAC   GC A Je T MCACAOCCGT T TCMA TGT .AC GTG6TCC  T lTCAGA6T TG \C TTe T AGAC TCAce TGTTe TCle cee TGTTTTM T  TCAAece AOC A T OCM T(reA 
1100 
AI.. TM. TAG A Tl Ge Teec TA AG( TGMCA GGAGGAGTC TGTG AGTTTCfGACACT GTTGTTGM ATGOC TAM fACM TGGGTA TCGe TGAGAe TAAGTTG TAGAU. T TAACMA fGTGe Ta: TG 
1800 I_ 
C  AAAA TGGC ' ACAeTtA TC TGAC TCA Tl  nT  He TA TfTTAGTTGGT nGU TC HOCC TAAGGTGCGTACT(CAA(TC TTGG TA TI Aece Tce TM T AGTeA TAC TAGTAG reATAe Teec TGGTGT 
2000 
AGTGT A T TC JC TAAAAOC T' TAAA 6 TC TOCA T OCAOCCAOCCA TeAM UG GI.A TG TC TC TCTT TGO  lGW TTACMMC TCAGAGAA.A TGTGT(A ICAGGAGl.A A TCA T Mcee  J GUGAA T A 
2100 
A ...... Ge C ce A . I ce l eT AA  TGA T Al T AGeAC T  TGC Tl AAGA T TTGGT  A AC T C TC T A" TAGe TGAG  GeA T TGAGC eA T GGT Ge T AM T Ge T ACA T AC TC e ...... c T GAM T GT T AAGGMC'aUG 
2200 2300 
A T,a,GA Te M TTA.MMU.A Tl AM ((MTTT ~GAACJlAGGAGA TCCCAGTC TA l TGAGfT AGCATAA TACA!iMGT CCC TC ACT TTAA( TTTT AeAAAMAG TAACCTGAAC TM 
2~ 
Tet G.A T GTT M eCM TG'A TTT A  H C TG GGTTCT GT TlCC TT T CC"" TTlGACMM CCACT GTTCTTGT" TTGTA na:; AGGGGGGAOC TA TCAC TCT AC nGr AGAGT G' ocr OC Tl T AA TC 
2S00 
CA TAAJ, reAcm TA Mf:CAAT TAGe TC TAT Me T M/!.AAAAMAAAMGCAeATCGA TACGGM Tl r- ----------- --------
.1-kb co I fra e t a d the 3. -  f ll-Ie gth i sert ere 
directly sequenced using double-stranded supercoiled plas-
ids (22, 23). or sequencing of double-stranded , best 
results ere obtained ith the 7  poly erase. or the 
3.5-kb subclone, only the region around the internal co I 
site as sequenced, de onstrating t at no s all frag ent 
as lost during subcloning. he restriction ap and sequenc-
ing strategy is sho n in Fig. 1. lone 9 has a long 5' -flanking 
region of 1020 bp, follo ed by an open reading fra e encoding 
34 a ino acids of a leader peptide, 310 a ino acids of the 
ature protein, and 1430 bp of a 3' -untranslated region 
ending in a poly(A) tail of 14 adenine residues. The entire 
sequence of clone 9 is sho n in Fig. 2. Recently, a partial 
genomic clone for  has been reported by us (12) and 
ikawa et al. (31) . The genomic clones contain al ost 600 bp 
of sequences upstrea  of the start of the  signal peptide. 
The nucleotide sequence of the 5/-fla i  region of clone 9 
(the c NA containing the C  gene) diverges fro  these 
genomic sequences at position -  upstrea  of the transla-
tional start. he genomic sequences surrounding nucleotide 
-46 could be interpreted as an acceptor splice signal (32) . To 
test the hypothesis, whether the divergence as due to an 
alternative splicing event in the precursor RNA, e re-
screened the cDNA library with a probe specific for the 5'-
flanking region of clone 9. Two independent clones (cDNA 
clones 13 and 2-3) with insert DNAs of 1.9 and 1.5 kb were 
obt i  a  arti l  sequenced (Fig. ). e  at  t e 
sequence o  the 5'  region  clone 9 (contai i  t e 
 gene) only str  o nucleotide -  hile t ere is 
 to the  ene do nstrea  o t is position, 
clones 13 a  2- show identical sequences, h ich akes 
t  likely to be transcripts o the sa e gene. ot  clones 
have the polyadenylation signal T AA, an  clone 13 pos-
sesses also 23 adenine residues. In addition, t e sequences 
surroundi  the position of divergence from clone 9 sho  no 
indication for a donor splice site. Further ore, Northern blot 
analysis o total R  obtai e  fro  S  403 cel s shows two 
NCA clone 9 AATGCTTT'l'CTAATG'l'A 'l' ACCTTGlIGTATTGCAG'1"l'GCTGCTT'l' 
clone 13 A TT ATG'l'A 'l'AA C'l.' GAG'r TTGCAGTTGCTGCT  
clone 2-  AATG TTCTAATG'l'AT'l'AACCTTGAGTAT'1'GCAG'1"l'GGCTT  
NCA clon. 9 
clone 13 
clone 2-3 
NCA clone 9 
c l one 13 
·46 1 
~ITCJ\ITAAN::cTlWW\AAAA 
GrN:. f'ACGIT~ITCJ\ITAAAa::r 
FIG. 3. Comparison o the clones 2-3 lind 13 it  l  9 
containing the N  gene. Sequenees upstrea  of nucleotide -4
are shared among the three clones (boldface IA! ers). Sequenees unique 
to the respe tive clones are in lightface !et ers. The putative polyad-
enylation signals are underlined. Numbering refers to clone 9. The 
translation al start site for NCA is shown in underlined boldface IA! rs_
NCA cDNA Clone 3205 
different size messages, depending on which fragments of 
clone 9  are used as probes. A 795-bp EcoRI/BsmI fragment 
from the 5'  end of clone 9 identifies a  distinct  7-kb message; 
while using the coding region of  NCA as  a probe, only a 2.5- 
kb band is seen, consistent with the length of the actual NCA 
gene in clone 9 (data not shown). For these reasons we 
conclude that  the first 974 nucleotides in clone 9 may be a 
cloning artifact  rather  than  the product of a splicing event in 
the 5"untranslated region of NCA and represent the 3'- 
untranslated sequence of an unrelated gene which has been 
fused to  the 5"untranslated region of the NCA gene. 
The amino-terminal sequences of NCA-55 and NCA-95 and 
a number of sequences from internal peptides of NCA-95 (11) 
are identical to  that predicted by the cDNA sequence. The 
directly determined amino acid composition of  NCA sequence 
contains 12 potential N-glycosylation sites, some of which 
were previously sequenced by Paxton et al. (11). 
A comparison of the NCA sequence to CEA (14) is shown 
in Fig. 4. CEA contains  three copies of the immunoglobulin- 
like repeat domain, only one of which is shown here. Three 
domains  are depicted: a 108-amino acid amino-terminal do- 
main which contains no cysteine residues, a 176-amino acid 
immunoglobulin-like domain containing two disulfide loops 
(4 cysteine residues), and  a 26-amino acid hydrophobic do- 
main. The first domain is identical to the amino-terminal 
107-amino acids of genomic  NCA shown by Thompson et al. 
(12). In the domains shown, the homology is 85% at  the amino 
acid level and 90% at  the nucleotide level. A comparison of 
homologies at  the nucleotide level of the  three copies of the 
repeated domain in CEA to  the single copy in NCA reveals 
the highest homology for the  first copy (90%) compared to 86 
and 83% for the second and third copies, respectively. Se- 
quence homology at  the nucleotide level continues to 40 bp 
beyond the stop codon, after which there is no apparent 
homology between both messages. The nucleotide sequence 
of approximately 800 bp of the 3"untranslated region of  CEA 
has been reported. CEA contains  a  truncated Alu sequence in 
its 3"untranslated region  which is lacking in NCA. 
FIG. 4. Comparison of CEA and NCA amino acid sequences. 
Numbers refer to  the NCA sequence. Onlv the  first Ie-like reueat of 
DISCUSSION 
Characterization of a cDNA clone containing the entire 
coding region of  NCA makes possible a detailed comparison 
of  NCA to CEA, the cDNA of which was recently cloned by 
Zimmermann et al. (13) and Oikawa et al. (14). A high  degree 
of sequence homology  was  previously noted by amino-termi- 
nal sequence analysis (11,  25) and by the extensive immuno- 
logical cross-reactions between CEA and NCA. Although 
amino acid differences between CEA and NCA occur through- 
out  their corresponding sequences (Fig. 4), there  are regions 
of perfect homology (e.g. residues 45-77) and regions with 
multiple substitutions (e.g. residues 164-196). The 4 cysteine 
residues of the Ig-like domain are conserved, as  are several 
residues that are  invariant in many immunoglobulin super- 
gene family sequences (11). 
There  are also differences in glycosylation sites. NCA con- 
tains 12 potential glycosylation sites, whereas CEA contains 
13 potential glycosylation sites for the corresponding se- 
quence. Of the 12 sites in NCA, 8 are conserved in CEA, the 
unique sites in NCA occur at residue 77 in the  amino-terminal 
domain and residues 139 and 190 in  the Ig-like domain. The 
five glycosylation sites unique to CEA  occur at residues 148, 
170,  174, 212, and 240, all within the repeated domain. From 
the number of potential glycosylation sites  in NCA, it  cannot 
be concluded whether this clone is equivalent to NCA-95 or 
NCA-55.  However, the similar amino acid compositions (Ta- 
ble I) and amino-terminal sequences (11) for both suggest 
that  the protein sequences are the same for both species of 
NCA. Limited studies on the glycosylation patterns of NCA 
indicate a mixture of bi-,  tri-,  and  tetraantennary Asn-linked 
carbohydrate chains (26). Assuming 12 biantennary chains 
(Mr = 2,20O/chain), NCA could  have a minimum molecular 
weight of 60,000. Assuming 12 tetraantennary  chains ( M ,  = 
4,40O/chain) NCA could have a maximum  molecular  weight 
of 86,000. Thus,  it is possible that  the two forms of NCA are 
different only in their glycosylation patterns. 
The regions of amino acid sequence differences, especially 
those which produce different glycosylation patterns,  are good 
candidates for antigenic differences between CEA and NCA. 
The length of the carboxyl-terminal domains are the same 
between  CEA and NCA and  both  are of sufficient hydropho- 
TABLE I 
Amino acid compositions of NCA-95,  NCA-55, and NCA  cDNA 
Data for NCA-95 and NCA-55 are  taken from Paxton et al. (11). 
Data  for Trp are  taken from Engvall et al. (25). Data for NCA cDNa 
are calculated from the nucleotide sequence. The predicted molecular 
weight for the mature  protein is 33,619, based on DNA sequence data. 
Amino acid NCA-95 NCA-55 NCA cDNA 
mol % 
%Cy5 1.6  1.4 
Asx 
1.3 
12.7 
Thr 
12.2 
8.4 
11.3 
8.3 
Ser 9.4 9.3 9.4 
Glx 11.3  11.6  10.0 
Pro 7.1 7.4 7.1 
GlY 6.9 8.1 
Ala 
6.8 
6.2 
Val 
6.2 
7.0 
7.1 
7.0 
Met 
8.1 
1.0 
Ile 
1.3 
4.4 
1.0 
4.3 5.5 
Leu 8.8  8.6  8.7 
TYr 4.8  4.8 
Phe 
3.9 
2.1 
His 
2.5  2.3 
1.9 
LY 8 2.8 
1.3 1.6 
3.2 
Arg 2.6  2.8  3.2 
2.6 
Tn, 2.0 1.6 
8.7 
CEA is shown. Amino acid differences are boxed. Cysteine residues 
are indicated by a solid circle. Asparagine-linked glycosylation sites 
are underlined. The three domains are indicated by arrows. -" 
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bicity and length to function in membrane insertion. These 
hydrophobic sequences are reminiscent of the carboxyl-ter- 
minal domain found in  the  Thy-1 antigen (27). 
Prior to amino acid sequence analysis of CEA ( l l ) ,  there 
was no indication that CEA or CEA-like antigens were  mem- 
bers of the immunoglobulin gene superfamily. Indeed, the 
biological function of CEA is still unknown. The discovery of 
the Ig-like domains in CEA  allows the prediction that these 
domains may  fold like adjacent domains of immunoglobulin 
(ie. CH2 and CH3). With respect to  the observed homology, 
a similar prediction can be made for the Ig-like domain in 
NCA. Cleavage of the disulfide bonds which connect the two 
sets of antiparallel @-sheets may lead to  the loss of antigenic 
activity in reduced and  S-alkylated CEA or NCA (28). Thus, 
the identification of immunologically reactive epitope-con- 
taining domains within CEA and NCA should be assisted by 
the predicted structure of immunoglobulin. As noted above, 
each copy of the repeat domains in CEA and NCA actually 
contain two Ig-like domains (equivalent to CH2 and CH3), 
which would be interactive, and also likely to form dimeric 
two-chain structures. Thus, it should now be possible to 
express the amino-terminal  and Ig-like domains of CEA or 
NCA independently and to test  the potential for an immu- 
noglobulin-like fold in these proteins directly. If the folding 
pattern is indeed like Ig, then  the glycosylation sites should 
be on the surface of the molecule. We are currently using 
molecular graphic techniques to simulate the structure of  CEA 
and NCA. Preliminary results  are in concordance with this 
model. Evolutionary relationships between CEA and NCA 
can be deduced from a comparison of their  structures.  First, 
it is likely that CEA  evolved from the simpler NCA gene by 
a process of gene duplication and subsequent divergence (Fig. 
5) .  In this view, the Ig-like domain doublet in NCA would 
have been copied  twice in CEA. It may also be expected that 
some other member of the CEA  gene family would have two 
copies of this repeated domain. The molecular weight of the 
128 kDa antigen (7) is of the right size for containing two but 
not  three copies.  We are  currently sequencing this antigen to 
test  this hypothesis. A comparison of the degree of  homology 
for each copy of these  repeats relative to each other  and NCA 
would  reveal the approximate time of gene duplication. Since 
NCA but  not CEA is found in lower mammals by immunolog- 
ical tests (29), it is likely that the duplication and gene 
0 Primitive  lg-like gene 
& +---ddlsulllde brldge 
N-term. domain Ig- l ike  domain 
NCA 
hydrophobic dorneln 
n n  n n  
, .,...= m 128 kDa Antigen 
1 
n n  n n  n n  
, ’ , : ‘I .“:c CEA 
FIG. 5. Postulated  evolution  of NCA and CEA genes from a 
primitive ancestor. The ancestral gene may have arisen from a 
single Ig-like gene and duplicated several times to produce this gene 
family. CEA  would  be the latest member of the family. 
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FIG. 6. Alignment of the amino-terminal and Ig-like do- 
mains in NCA. The first two lines compare the amino acid sequences 
of the two domains, starting  the alignment 6 residues within the Ig- 
like domain. Homologies  which  were obtained by dot matrix align- 
ments  are indicated with boxes, allowing conservative replacements 
for the groups S,T,G,A,P; Q,N,D,E; H,R,K; I,V,L,M and Y,F,W. 
Possible positional displacements are also shown. Maximal homology 
requires the separate consideration of residues 44-62 (see Oikawa et 
al. (30)). The second pair of lines compares @-strand predictions using 
the Chou-Fasman algorithm and aligning the Ig-like domain with the 
CH2 domain of immunoglobulin. Predicted @-strands  are shown with 
a b and interconnecting loops or turns are shown with a t .  Residues 
44-62 may correspond to an extra ,%strand not found in immuno- 
globulin. The size of the homologous domains roughly corresponds to 
one immunoglobulin domain. Invariant residues of the immunoglob- 
ulin supergene family members are shown above the amino acid 
comparisons. 
expansion event occurred recently, along with the divergence 
of higher primates. 
The amino-terminal domain has low but significant ho- 
mology to  the Ig-like domain (Fig. 6), suggesting that  it also 
is related to immunoglobulin. The homology is low at  the 
nucleotide level (30%), but higher at the amino acid level 
(40%), if one allows for conservative replacements and pos- 
sible positional shifts. The positional shifts  are reasonable, 
given the overall @-sheet structure prediction for this domain. 
The size of the amino-terminal domain may indicate that  it 
corresponds to one-half the Ig-like domain doublet or the 
equivalent of a single  CH2 or CH3 domain in immunoglobu- 
lins. Alignment of CH2 or CH3 to one-half of this NCA 
domain results in the assignment of seven P-strands. If the 
amino-terminal domain is aligned to the Ig-like domain in 
NCA, seven @-strands also are found. The low  homology,  lack 
of the disulfide loops, and the size difference suggest that 
extensive divergence  would  have had to occur to explain its 
origin from the Ig-like domains in this molecule.  More impor- 
tantly,  the dissimilarity of the amino-terminal domain from 
the Ig-like domains calls attention  to  its probable different 
functional aspect. Since the biological function of these mol- 
ecules is still unknown, we await the results of further exper- 
iments to assign functions to individual domains. 
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